Latest News

Here you can find all the latest news from the MRC CTU at UCL.

Long-term follow-up results from the PIVOT trial confirm that protease inhibitor monotherapy preserves future drug options as well as standard combination therapy.
For our 25th anniversary celebrations, we explore the PRACTical trial design, which allows researchers to compare multiple treatments for diseases that don’t have a single “standard-of-care” treatment.
This new route will allow to study part-time as part of an integrated apprenticeship, providing the level 7 qualification as a medical statistician.
H-PRIME will investigate the best way to treat sickle cell disease in Ugandan children using a factorial trial design.
This World Cancer Day, we highlight how our research has contributed towards picking up ovarian cancer earlier with one of the largest screening trials in ovarian cancer, the UKCTOCS trial.